T-cell large granular lymphocyte leukemia
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:ALK
|
| gptkbp:affects |
T-cells
|
| gptkbp:associated_with |
cytopenias
|
| gptkbp:can_lead_to |
immunosuppression
|
| gptkbp:clinical_trial |
ongoing
completed recruiting phase 1 phase 2 phase 3 |
| https://www.w3.org/2000/01/rdf-schema#label |
T-cell large granular lymphocyte leukemia
|
| gptkbp:is_characterized_by |
large granular lymphocytes
|
| gptkbp:is_involved_in |
gptkb:stock_market_index
online local |
| gptkbp:is_monitored_by |
imaging studies
regular blood tests bone marrow assessments symptom tracking |
| gptkbp:is_often_used_in |
adults
males |
| gptkbp:public_awareness |
gptkb:Educational_Institution
important community support |
| gptkbp:research_focus |
genetic mutations
treatment efficacy disease progression |
| gptkbp:risk_factor |
viral infections
autoimmune disorders exposure to chemicals |
| gptkbp:social_responsibility |
variable
bone marrow biopsy depends on age depends on response to treatment depends on overall health |
| gptkbp:symptoms |
fatigue
weight loss fever night sweats enlarged lymph nodes |
| gptkbp:treatment |
gptkb:vaccine
variable chemotherapy targeted therapy depends on subtype depends on patient factors |
| gptkbp:type_of |
chronic
acute |